17-Avp-786-205
Research payments
$2,890,374
Through program year 2022, $2,890,374 in research payments was reported against 17-Avp-786-205, across 666 payments, paid by Avanir Pharmaceuticals, Inc..
- Paid by
- Avanir Pharmaceuticals, Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2022 | Research | $463,893 | 303 |
| 2021 | Research | $1,601,573 | 197 |
| 2020 | Research | $674,551 | 115 |
| 2019 | Research | $150,356 | 51 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Marina Raikhel Lomita, CA Named on 64 payments
- Siddharth Kaul Bridgeton, MO Named on 33 payments
- Eva-Maria Heurich Maitland, FL Named on 30 payments
- Surendra Barshikar Neptune, NJ Named on 29 payments
- Orlando Maldonado Bradenton, FL Named on 28 payments
- Mohammad Asim Nisar Okeechobee, FL Named on 19 payments
- Mamta Sapra Salem, VA Named on 19 payments
- Allan Block Scottsdale, AZ Named on 17 payments
- Kore Liow Kailua, HI Named on 17 payments
- Deborah Burke Sarasota, FL Named on 17 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.